Evidence map›Paper›PMID 40503554›Full record

ArticleThe Canadian journal of hospital pharmacy2025

Use of Buprenorphine/Naloxone in an Adult with Cystic Fibrosis.

Tamara Mihic, Nadia Fairbairn, Seonaid Nolan, Renée Dagenais, Bradley S Quon, M Eugenia Socias

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Canadian journal of hospital pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tamara MihicBSc(Pharm), ACRP, PharmD, is with St Paul's Hospital, the British Columbia Centre on Substance Use, and the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia.
Nadia FairbairnMD, FRCPC, MHSc, is with St Paul's Hospital, the British Columbia Centre on Substance Use, and the Department of Medicine, The University of British Columbia, Vancouver, British Columbia.
Seonaid NolanMD, FRCPC, DRCPSC, is with St Paul's Hospital, the British Columbia Centre on Substance Use, and the Department of Medicine, The University of British Columbia, Vancouver, British Columbia.
Renée DagenaisBSc(Pharm), ACRP, PharmD, is with St Paul's Hospital and the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia.
Bradley S QuonMD, FRCPC, MSc, MBA, is with St Paul's Hospital and the Department of Medicine, The University of British Columbia, Vancouver, British Columbia.
M Eugenia SociasMD, MSc, is with the British Columbia Centre on Substance Use and the Department of Medicine, The University of British Columbia, Vancouver, British Columbia.

Funding

Mentoring the next generation of addiction clinician scientists while responding to the opioid epidemicR25DA037756 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI FAIRBAIRN, NADIA · 2014 to 2023
$3.6M
NIDA NIH HHS R25 DA037756
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40503554
PMCPMC12119097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.